Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Borghi
Prevalence of HIV-1 Integrase Mutations Related to Resistance to Dolutegravir in Raltegravir Naïve and Pretreated Patients
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Related publications
Figure 1: FDA Approved Integrase Strand Transfer Inhibitors INSTIs: Raltegravir, Elvitegravir and Dolutegravir.
Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population From Northern India
AIDS Research and Treatment
Immunology
Public Health
Allergy
Environmental
Dermatology
Infectious Diseases
Occupational Health
Impact of HIV-1 Integrase L74F and V75I Mutations in a Clinical Isolate on Resistance to Second-Generation Integrase Strand Transfer Inhibitors
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance Against the Integrase Inhibitor Dolutegravir”
mBio
Virology
Microbiology
Mutations Associated With Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor in Vitro
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Improving Access to Antiretrovirals in China: Economic Analyses of Dolutegravir in HIV-1 Patients
Cost Effectiveness and Resource Allocation
Health Policy
HIV-1 Molecular Characterization and Transmitted Drug Resistance Prevalence Among Treatment-Naïve Individuals
Journal of AIDS and HIV Infections
HIV-1 Transmitted Drug Resistance Mutations Among Antiretroviral Therapy-Naïve Individuals in Surabaya, Indonesia
AIDS Research and Therapy
Virology
Molecular Medicine
Pharmacology
Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing
Journal of Infectious Diseases
Infectious Diseases
Allergy
Immunology
